Skip to Main Content

Paper Details

Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapy.
Nature
41
2023
CD8, CD8 T, CD8 T cell, CD8 T cells, Cas9, HLA, HLA allele, HLAs, PD-1, T cell, T cell clonotypes, T cell receptors, T cells, TCR, anti-PD-1, antitumour, antitumour T cells, human leukocyte antigens, immunodominant mutations, melanoma, metastatic melanoma, neoTCR, neoTCR clonotypes, neoTCR sequences, neoTCRs, neoantigen-specific T cells, patient, patient-matched melanoma cell lines, patients, polyclonal, polyclonal CD8 T cells, tumour, tumours
Author NameAffiliation
Jasreet HundalMcDonnell Genome Institute, Washington University School of Medicine
Bartosz ChmielowskiUniversity of California Los Angeles
Bartosz ChmielowskiJonsson Comprehensive Cancer Center, university of california los angeles
Obi L GriffithMcDonnell Genome Institute, Washington University School of Medicine
Malachi GriffithMcDonnell Genome Institute, Washington University School of Medicine
James R HeathInstitute for Systems Biology
Antoni RibasUniversity of California Los Angeles
Antoni RibasJonsson Comprehensive Cancer Center, university of california los angeles
Antoni RibasParker Institute for Cancer Immunotherapy
Antoni RibasBroad Stem Cell Research Center, university of california los angeles
Antoni RibasUniversity of California Los Angeles
Antoni RibasJonsson Comprehensive Cancer Center, university of california los angeles
Antoni RibasParker Institute for Cancer Immunotherapy
Antoni RibasBroad Stem Cell Research Center, university of california los angeles
  • 1 - 14

Datasets

Release 1.2